Viremia, resuppression, and the time to resistance in HIV subtype C during first-line antiretroviral therapy in South Africa

Among patients developing viremia on first-line HAART in a South African cohort, 41% resuppressed without regimen switch. At first detection of viremia, 66% had any resistance mutations and 4% had thymidine analogue mutations (TAMs). After 12 months of viremia, 14% had TAMs. BACKGROUND: Episodes of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hoffmann, CJ, Charalambous, S, Sim, J, Ledwaba, J, Schwikkard, G, Chaisson, RE, Fielding, K, Churchyard, G, Morris, L, Grant, AD
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2789416/
https://ncbi.nlm.nih.gov/pubmed/19911963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/648444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados